Off-the-shelf CAR-natural killer cells could expand accessibility, reduce cost of cell-based cancer therapies
New cellular immunotherapy approach shows promise for B-cell lymphoma
View Content
Off-the-shelf CAR-natural killer cells could expand accessibility, reduce cost of cell-based cancer therapies